Amarin reported $-13630000 in Pre-Tax Profit for its fiscal quarter ending in March of 2025.


Pre Tax Profit Change Date
AbbVie USD 1.66B 3.15B Mar/2025
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Amarin USD -13630000 197K Mar/2025
AstraZeneca USD 3.13B 275M Jun/2025
DBV Technologies EUR -41758000 18.75M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
Halozyme Therapeutics USD 204.94M 61.11M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
Neurocrine Biosciences USD 159.5M 144.8M Jun/2025
Novartis USD 4.53B 124M Jun/2025